|Bid||17.61 x 0|
|Ask||17.66 x 0|
|Day's Range||16.95 - 17.62|
|52 Week Range||12.91 - 18.30|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 7, 2019|
|Forward Dividend & Yield||0.20 (1.33%)|
|1y Target Est||15.93|
The big shareholder groups in HLS Therapeutics Inc. (TSE:HLS) have power over the company. Institutions will often...
TORONTO , Oct. 17, 2019 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (HLS.TO), a specialty pharmaceutical company focusing on central nervous system and cardiovascular markets, announces that Health Canada has granted a medical device license for the Athelas One WBC System for use as a point-of-care device indicated for quantitative determination of white blood cells (WBC) and neutrophil percentages in capillary or venous whole blood. This medical device may help enhance and simplify the mandatory safety blood monitoring process for Treatment Resistant Schizophrenia ("TRS") patients that are prescribed Clozaril® (clozapine).
Today we'll take a closer look at HLS Therapeutics Inc. (TSE:HLS) from a dividend investor's perspective. Owning a...
Readers hoping to buy HLS Therapeutics Inc. (TSE:HLS) for its dividend will need to make their move shortly, as the...
ETOBICOKE, ON , May 14, 2019 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (HLS.TO) today announced that it has entered into a bought deal agreement with GMP Securities L.P. and Bloom Burton Securities Inc. (together, the "Lead Underwriters"), pursuant to which the Lead Underwriters have agreed to purchase 2,718,750 common shares of the Company (the "Common Shares") at a price of $16.00 per Common Share (the "Issue Price") for gross proceeds of $43,500,000 (the "Offering"). In addition, the underwriters of the Offering will have the option, exercisable until 30 days after the closing date, to acquire up to an aggregate of 407,813 additional Common Shares at the Issue Price to cover over-allotments, if any (the "Over-Allotment Option").
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! A look at the shareholders of HLS Therapeutics Inc. (TSE:HLS) can tell us which group is most powerfu...